{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:46:26Z","timestamp":1772642786344,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10151-018-1906-y","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T13:54:32Z","timestamp":1546437272000},"page":"905-917","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Management of anoperineal lesions\u00a0in Crohn\u2019s disease: a French National Society of Coloproctology national consensus"],"prefix":"10.1007","volume":"22","author":[{"given":"D.","family":"Bouchard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pigot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Staumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Siproudhis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Abramowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Benfredj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Brochard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Fathallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Faucheron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Higuero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Panis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"de Parades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Vinson-Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Laharie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,2]]},"reference":[{"key":"1906_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10151-017-1684-y","volume":"21","author":"D Bouchard","year":"2017","unstructured":"Bouchard D, Abramowitz L, Bouguen G, Brochard C, Dabadie A, de Parades V, Eleuet-Kaplan M, Fathallah N, Faucheron J-L, Maggiori L, Panis Y, Pigot F, Roume P, Roumeguere P, S\u00e9n\u00e9joux A, Siproudhis L, Staumont G, Suduca J-M, Vinson-Bonnet B, Zeitoun J-D (2017) Anoperineal lesions in Crohn\u2019s disease: French recommendations for clinical practice. Tech Coloproctol 21:683\u2013691. \n                    https:\/\/doi.org\/10.1007\/s10151-017-1684-y","journal-title":"Tech Coloproctol"},{"key":"1906_CR2","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/BF02253493","volume":"35","author":"LE Hughes","year":"1992","unstructured":"Hughes LE (1992) Clinical classification of perianal Crohn\u2019s disease. Dis Colon Rectum 35:928\u2013932","journal-title":"Dis Colon Rectum"},{"key":"1906_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/bjs.1800630102","volume":"63","author":"AG Parks","year":"1976","unstructured":"Parks AG, Gordon PH, Hardcastle JD (1976) A classification of fistula-in-ano. Br J Surg 63:1\u201312","journal-title":"Br J Surg"},{"key":"1906_CR4","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.gastro.2003.08.025","volume":"125","author":"WJ Sandborn","year":"2003","unstructured":"Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB (2003) American Gastroenterological Association Clinical Practice Committee. AGA technical review on perianal Crohn\u2019s disease. Gastroenterology 125:1508\u20131530","journal-title":"Gastroenterology"},{"key":"1906_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/BF02053756","volume":"35","author":"A Allan","year":"1992","unstructured":"Allan A, Linares L, Spooner HA, Alexander-Williams J (1992) Clinical index to quantitate symptoms of perianal Crohn\u2019s disease. Dis Colon Rectum 35:656\u2013661","journal-title":"Dis Colon Rectum"},{"key":"1906_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00004836-199501000-00008","volume":"20","author":"EJ Irvine","year":"1995","unstructured":"Irvine EJ (1995) Usual therapy improves perianal Crohn\u2019s disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 20:27\u201332","journal-title":"J Clin Gastroenterol"},{"key":"1906_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1148\/radiology.218.1.r01dc0575","volume":"218","author":"RG Beets-Tan","year":"2001","unstructured":"Beets-Tan RG, Beets GL, van der Hoop AG et al (2001) Preoperative MR imaging of anal fistulas: does it really help the surgeon? Radiology 218:75\u201384","journal-title":"Radiology"},{"key":"1906_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1148\/radiol.2333031724","volume":"233","author":"GN Buchanan","year":"2004","unstructured":"Buchanan GN, Halligan S, Bartram CI, Williams AB, Tarroni D, Cohen CR (2004) Clinical examination, endosonography, and MR imaging in preoperative assessment of fistula in ano: comparison with outcome-based reference standard. Radiology 233:674\u2013681","journal-title":"Radiology"},{"key":"1906_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1046\/j.1365-2168.1999.01020.x","volume":"86","author":"P Orsoni","year":"1999","unstructured":"Orsoni P, Barthet M, Portier F, Panuel M, Desjeux A, Grimaud JC (1999) Prospective comparison of endosonography, magnetic resonance imaging and surgical findings in anorectal fistula and abscess complicating Crohn\u2019s disease. Br J Surg 86:360\u2013364","journal-title":"Br J Surg"},{"key":"1906_CR10","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1053\/gast.2001.28676","volume":"121","author":"DA Schwartz","year":"2001","unstructured":"Schwartz DA, Wiersema MJ, Dudiak KM et al (2001) A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn\u2019s perianal fistulas. Gastroenterology 121:1064\u20131072","journal-title":"Gastroenterology"},{"key":"1906_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4291\/wjgp.v5.i3.239","volume":"5","author":"R Sordo-Mejia","year":"2014","unstructured":"Sordo-Mejia R, Gaertner WB (2014) Multidisciplinary and evidence-based management of fistulizing perianal Crohn\u2019s disease. World J Gastrointest Pathophysiol 5:239\u2013251","journal-title":"World J Gastrointest Pathophysiol"},{"key":"1906_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ibd.20608","volume":"15","author":"KT Thia","year":"2009","unstructured":"Thia KT, Mahadevan U, Feagan BG et al (2009) Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn\u2019s disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 15:17\u201324","journal-title":"Inflamm Bowel Dis"},{"key":"1906_CR13","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/bjs.7121","volume":"97","author":"Y Maeda","year":"2010","unstructured":"Maeda Y, Ng SC, Durdey P et al (2010) Topical metronidazole in perianal Crohn\u2019s Study Group. Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn\u2019s disease. Br J Surg 97:1340\u20131347","journal-title":"Br J Surg"},{"key":"1906_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/gutjnl-2013-304488","volume":"63","author":"P Dewint","year":"2014","unstructured":"Dewint P, Hansen BE, Verhey E et al (2014) Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn\u2019s disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut 63:292\u2013299","journal-title":"Gut"},{"key":"1906_CR15","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/j.1365-2036.2004.02247.x","volume":"20","author":"RL West","year":"2004","unstructured":"West RL, van der Woude CJ, Hansen BE et al (2004) Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulas in Crohn\u2019s disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther 20:1329\u20131336","journal-title":"Aliment Pharmacol Ther"},{"key":"1906_CR16","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","volume":"8","author":"FM Ruemmele","year":"2014","unstructured":"Ruemmele FM, Veres G, Kolho KL et al (2014) European Crohn\u2019s and Colitis Organisation; European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn\u2019s disease. J Crohns Colitis 8:1179\u20131207","journal-title":"J Crohns Colitis"},{"key":"1906_CR17","first-page":"CD006827","volume":"7","author":"AI Malik","year":"2010","unstructured":"Malik AI, Nelson RL, Tou S (2010) Incision and drainage of perianal abscess with or without treatment of anal fistula. Cochrane Database Syst Rev 7:CD006827","journal-title":"Cochrane Database Syst Rev"},{"key":"1906_CR18","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1463-1318.2012.02944.x","volume":"14","author":"G El-Gazzaz","year":"2012","unstructured":"El-Gazzaz G, Hull T, Church JM (2012) Biological immunomodulators improve the healing rate in surgically treated perianal Crohn\u2019s fistulas. Colorectal Dis 14:1217\u20131223","journal-title":"Colorectal Dis"},{"key":"1906_CR19","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s10350-006-0656-5","volume":"49","author":"SA Hyder","year":"2006","unstructured":"Hyder SA, Travis SP, Jewell DP, Mortensen NJM, George BD (2006) Fistulating anal Crohn\u2019s disease: results of combined surgical and infliximab treatment. Dis Colon Rectum 49:1837\u20131841","journal-title":"Dis Colon Rectum"},{"key":"1906_CR20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/apt.12906","volume":"40","author":"NA Yassin","year":"2014","unstructured":"Yassin NA, Askari A, Warusavitarne J et al (2014) Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn\u2019s disease. Aliment Pharmacol Ther 40:741\u2013749","journal-title":"Aliment Pharmacol Ther"},{"key":"1906_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00054725-200303000-00003","volume":"9","author":"M Regueiro","year":"2003","unstructured":"Regueiro M, Mardini H (2003) Treatment of perianal fistulizing Crohn\u2019s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis 9:98\u2013103","journal-title":"Inflamm Bowel Dis"},{"key":"1906_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/MPG.0b013e3181a70f21","volume":"49","author":"W Crandall","year":"2009","unstructured":"Crandall W, Hyams J, Kugathasan S et al (2009) Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACH. J Pediatr Gastroenterol Nutr 49:183\u2013190","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1906_CR23","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/apt.12928","volume":"40","author":"C Dupont-Lucas","year":"2014","unstructured":"Dupont-Lucas C, Dabadie A, Alberti C, Ruemmele FM (2014) GETAID (Group d\u2019Etude Th\u00e9rapeutique des Affections Inflammatoires du Tube Digestif) P\u00e9diatrique. Predictors of response to infliximab in paediatric perianal Crohn\u2019s disease. Aliment Pharmacol Ther 40:917\u2013929","journal-title":"Aliment Pharmacol Ther"},{"key":"1906_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/codi.13672","volume":"19","author":"MJ Lee","year":"2017","unstructured":"Lee MJ, Heywood N, Sagar PM, Brown SR, Fearnhead NS, ACPGBI Perianal Crohn\u2019s Disease Group (2017) Association of Coloproctology of Great Britain and Ireland consensus exercise on surgical management of fistulating perianal Crohn\u2019s disease. Colorectal Dis 19:418\u2013429","journal-title":"Colorectal Dis"},{"key":"1906_CR25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1463-1318.2009.01810.x","volume":"12","author":"M Vial","year":"2010","unstructured":"Vial M, Par\u00e9s D, Pera M, Grande L (2010) Faecal incontinence after seton treatment for anal fistulae with and without surgical division of internal anal sphincter: a systematic review. Colorectal Dis 12:172\u2013178","journal-title":"Colorectal Dis"},{"key":"1906_CR26","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/DCR.0000000000000628","volume":"59","author":"H Zhang","year":"2016","unstructured":"Zhang H, Zhou ZY, Hu B et al (2016) Clinical significance of 2 deep posterior perianal spaces to complex cryptoglandular fistulas. Dis Colon Rectum 59:766\u2013774","journal-title":"Dis Colon Rectum"},{"key":"1906_CR27","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1148\/radiol.2016151491","volume":"282","author":"SP Sheedy","year":"2017","unstructured":"Sheedy SP, Bruining DH, Dozois EJ, Faubion WA, Fletcher JG (2017) MR imaging of perianal crohn disease. Radiology 282:628\u2013645","journal-title":"Radiology"},{"key":"1906_CR28","first-page":"3","volume":"57","author":"S Tanaka","year":"2010","unstructured":"Tanaka S, Matsuo K, Sasaki T et al (2010) Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn\u2019s disease: when and how were the seton drains removed? Hepatogastroenterology 57:3\u20137","journal-title":"Hepatogastroenterology"},{"key":"1906_CR29","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH, Rutgeerts P, Targan S et al (1999) Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease. N Engl J Med 340:1398\u20131405","journal-title":"N Engl J Med"},{"key":"1906_CR30","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJMoa030815","volume":"350","author":"BE Sands","year":"2000","unstructured":"Sands BE, Anderson FH, Bernstein CN et al (2000) Infliximab maintenance therapy for fistulizing Crohn\u2019s disease. N Engl J Med 350:876\u2013885","journal-title":"N Engl J Med"},{"key":"1906_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","volume":"132","author":"JF Colombel","year":"2007","unstructured":"Colombel JF, Sandborn WJ, Rutgeerts P et al (2007) Adalimumab for maintenance of clinical response and remission in patients with Crohn\u2019s disease: the CHARM trial. Gastroenterology 132:52\u201365","journal-title":"Gastroenterology"},{"key":"1906_CR32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.crohns.2010.07.012","volume":"4","author":"A Echarri","year":"2010","unstructured":"Echarri A, Castro J, Barreiro M, Carpio D, Pereira S, Lorenzo A (2010) Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn\u2019s disease patients with infliximab failure. J Crohns Colitis 4:654\u2013660","journal-title":"J Crohns Colitis"},{"key":"1906_CR33","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/ajg.2011.73","volume":"106","author":"AC Ford","year":"2011","unstructured":"Ford AC, Sandborn WJ, Khan KJ et al (2011) Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 106:644\u2013659","journal-title":"Am J Gastroenterol"},{"key":"1906_CR34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/apt.13288","volume":"42","author":"W Moon","year":"2015","unstructured":"Moon W, Pestana L, Becker B, Loftus EV Jr, Hanson KA, Bruining DH, Tremaine WJ, Kane SV (2015) Efficacy and safety of certolizumab pegol for Crohn\u2019s disease in clinical practice. Aliment Pharmacol Ther 42:428\u2013440","journal-title":"Aliment Pharmacol Ther"},{"key":"1906_CR35","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1215739","volume":"369","author":"WJ Sandborn","year":"2013","unstructured":"Sandborn WJ, Feagan BG, Rutgeerts P et al (2013) GEMINI 2 Study Group. Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease. N Engl J Med 369:711\u2013721","journal-title":"N Engl J Med"},{"key":"1906_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.7326\/0003-4819-123-2-199507150-00009","volume":"123","author":"DC Pearson","year":"1995","unstructured":"Pearson DC, May GR, Fick GH, Sutherland LR (1995) Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 123:132\u2013142","journal-title":"Ann Intern Med"},{"key":"1906_CR37","first-page":"CD000545","volume":"6","author":"E Prefontaine","year":"2010","unstructured":"Prefontaine E, Macdonald JK, Sutherland LR (2010) Azathioprine or 6-mercaptopurine for induction of remission in Crohn\u2019s disease. Cochrane Database Syst Rev 6:CD000545","journal-title":"Cochrane Database Syst Rev"},{"key":"1906_CR38","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1053\/j.gastro.2013.04.048","volume":"145","author":"J Cosnes","year":"2013","unstructured":"Cosnes J, Bourrier A, Laharie D et al (2013) Groupe d\u2019Etude Th\u00e9rapeutique des Affections Inflammatoires du Tube Digestif (GETAID). Early administration of azathioprine vs conventional management of Crohn\u2019s disease: a randomized controlled trial. Gastroenterology 145:758\u2013765","journal-title":"Gastroenterology"},{"key":"1906_CR39","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2013.06.009","volume":"145","author":"J Pan\u00e9s","year":"2013","unstructured":"Pan\u00e9s J, L\u00f3pez-Sanrom\u00e1n A, Bermejo F et al, AZTEC Study Group (2013) Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn\u2019s disease. Gastroenterology 145:766\u2013774","journal-title":"Gastroenterology"},{"key":"1906_CR40","first-page":"CD000067","volume":"10","author":"N Chande","year":"2015","unstructured":"Chande N, Patton PH, Tsoulis DJ, Thomas BS, MacDonald JK (2015) Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn\u2019s disease. Cochrane Database Syst Rev 10:CD000067","journal-title":"Cochrane Database Syst Rev"},{"key":"1906_CR41","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/DCR.0b013e3181b55560","volume":"52","author":"S Gonsalves","year":"2009","unstructured":"Gonsalves S, Sagar P, Lengyel J, Morrison C, Dunham R (2009) Assessment of the efficacy of the rectovaginal button fistula plug for the treatment of ileal pouch-vaginal and rectovaginal fistulas. Dis Colon Rectum 52:1877\u20131881","journal-title":"Dis Colon Rectum"},{"key":"1906_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ibd.20073","volume":"13","author":"AL Hart","year":"2007","unstructured":"Hart AL, Plamondon S, Kamm MA (2007) Topical tacrolimus in the treatment of perianal Crohn\u2019s disease: exploratory randomized controlled trial. Inflamm Bowel Dis 13:245\u2013253","journal-title":"Inflamm Bowel Dis"},{"key":"1906_CR43","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","volume":"362","author":"JF Colombel","year":"2010","unstructured":"Colombel JF, Sandborn WJ, Reinisch W et al (2010) SONIC Study Group. Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease. N Engl J Med 362:1383\u20131395","journal-title":"N Engl J Med"},{"key":"1906_CR44","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.cgh.2012.12.042","volume":"11","author":"G Bouguen","year":"2013","unstructured":"Bouguen G, Siproudhis L, Gizard E et al (2013) Long-term outcome of perianal fistulizing Crohn\u2019s disease treated with infliximab. Clin Gastroenterol Hepatol 11:975\u2013981.e1\u20134","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1906_CR45","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1053\/j.gastro.2015.06.014","volume":"149","author":"I Molendijk","year":"2015","unstructured":"Molendijk I, Bonsing BA, Roelofs H et al (2015) Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology 149:918\u2013927.e6","journal-title":"Gastroenterology"},{"key":"1906_CR46","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Pan\u00e9s","year":"2016","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G et al, ADMIRE CD Study Group Collaborators (2016) Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial. Lancet 388:1281\u20131290","journal-title":"Lancet"},{"key":"1906_CR47","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1572-0241.2003.07241.x","volume":"98","author":"G Assche Van","year":"2003","unstructured":"Van Assche G, Vanbeckevoort D, Bielen D et al (2003) Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn\u2019s disease. Am J Gastroenterol 98:332\u2013339","journal-title":"Am J Gastroenterol"},{"key":"1906_CR48","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1007\/s10620-008-0545-y","volume":"54","author":"D Tougeron","year":"2009","unstructured":"Tougeron D, Savoye G, Savoye-Collet C, Koning E, Michot F, Lerebours E (2009) Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn\u2019s disease. Dig Dis Sci 54:1746\u20131752","journal-title":"Dig Dis Sci"},{"key":"1906_CR49","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10151-017-1647-3","volume":"21","author":"GC Braithwaite","year":"2017","unstructured":"Braithwaite GC, Lee MJ, Hind D, Brown SR (2017) Prognostic factors affecting outcomes in fistulating perianal Crohn\u2019s disease: a systematic review. Tech Coloproctol 21:501\u2013519. \n                    https:\/\/doi.org\/10.1007\/s10151-017-1647-3","journal-title":"Tech Coloproctol"},{"key":"1906_CR50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cgh.2010.10.022","volume":"9","author":"K Karmiris","year":"2011","unstructured":"Karmiris K, Bielen D, Vanbeckevoort D et al (2011) Long-term monitoring of infliximab therapy for perianal fistulizing Crohn\u2019s disease by using magnetic resonance imaging. Clin Gastroenterol Hepatol 9:130\u2013136","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1906_CR51","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/ibd.21568","volume":"17","author":"C Savoye-Collet","year":"2011","unstructured":"Savoye-Collet C, Savoye G, Koning E, Dacher JN, Lerebours E (2011) Fistulizing perianal Crohn\u2019s disease: contrast-enhanced magnetic resonance imaging assessment at 1\u00a0year on maintenance anti-TNF-alpha therapy. Inflamm Bowel Dis 17:1751\u20131758","journal-title":"Inflamm Bowel Dis"},{"key":"1906_CR52","doi-asserted-by":"publisher","first-page":"9 40","DOI":"10.1136\/gut.2008.159251","volume":"58","author":"JF Colombel","year":"2009","unstructured":"Colombel JF, Schwartz DA, Sandborn WJ et al (2009) Adalimumab for the treatment of fistulas in patients with Crohn\u2019s disease. Gut 58:9 40\u201348","journal-title":"Gut"},{"key":"1906_CR53","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1007\/s10350-007-9077-3","volume":"50","author":"WB Gaertner","year":"2007","unstructured":"Gaertner WB, Decanini A, Mellgren A et al (2007) Does infliximab infusion impact results of operative treatment for Crohn\u2019s perianal fistulas? Dis Colon Rectum 50:1754\u20131760","journal-title":"Dis Colon Rectum"},{"key":"1906_CR54","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/codi.12851","volume":"17","author":"A Haenning","year":"2015","unstructured":"Haenning A, Staumont G, Lepage B et al (2015) The results of seton drainage combined with anti-TNF therapy for anal fistula in Crohn\u2019s disease. Colorectal Dis 17:311\u2013319","journal-title":"Colorectal Dis"},{"key":"1906_CR55","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1053\/j.gastro.2005.01.048","volume":"128","author":"GR Lichtenstein","year":"2005","unstructured":"Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE (2005) Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulising Crohn\u2019s disease. Gastroenterology 128:862\u2013869","journal-title":"Gastroenterology"},{"key":"1906_CR56","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1053\/j.gastro.2008.07.069","volume":"135","author":"BG Feagan","year":"2008","unstructured":"Feagan BG, Panaccione R, Sandborn WJ et al (2008) Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn\u2019s disease: results from the CHARM study. Gastroenterology 135:1493\u20131499","journal-title":"Gastroenterology"},{"key":"1906_CR57","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/j.1365-2036.2006.02878.x","volume":"23","author":"BE Sands","year":"2006","unstructured":"Sands BE, Blank MA, Diamond RH, Barrett JP, Van Deventer SJ (2006) Maintenance infliximab does not result in increased abscess development in fistulising Crohn\u2019s disease: results from the ACCENT II study. Aliment Pharmacol Ther 23:1127\u20131136","journal-title":"Aliment Pharmacol Ther"},{"key":"1906_CR58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ibd.21405","volume":"17","author":"P Roumegu\u00e8re","year":"2011","unstructured":"Roumegu\u00e8re P, Bouchard D, Pigot F et al (2011) Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn\u2019s disease: results from a prospective study. Inflamm Bowel Dis 17:69\u201376","journal-title":"Inflamm Bowel Dis"},{"key":"1906_CR59","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1053\/j.gastro.2010.02.013","volume":"138","author":"JC Grimaud","year":"2010","unstructured":"Grimaud JC, Munoz-Bongrand N, Siproudhis L et al (2010) Groupe d\u2019Etude Th\u00e9rapeutique des Affections Inflammatoires du Tube Digestif. Fibrin glue is effective healing perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology 138:2275\u20132281, 2281.e1","journal-title":"Gastroenterology"},{"key":"1906_CR60","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/ecco-jcc\/jjv162","volume":"10","author":"A Sen\u00e9joux","year":"2016","unstructured":"Sen\u00e9joux A, Siproudhis L, Abramowitz L et al (2016) Groupe d\u2019Etude Th\u00e9rapeutique des Affections Inflammatoires du tube Digestif [GETAID]. Fistula plug in fistulising ano-perineal Crohn\u2019s disease: a randomised controlled trial. J Crohns Colitis 10:141\u2013148","journal-title":"J Crohns Colitis"},{"key":"1906_CR61","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/SLA.0000000000000479","volume":"260","author":"DS Gingold","year":"2014","unstructured":"Gingold DS, Murrell ZA, Fleshner PR (2014) A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn\u2019s disease. Ann Surg 260:1057\u20131061","journal-title":"Ann Surg"},{"key":"1906_CR62","first-page":"147","volume":"64","author":"JS Joo","year":"1998","unstructured":"Joo JS, Weiss EG, Nogueras JJ, Wexner SD (1998) Endorectal advancement flap in perianal Crohn\u2019s disease. Am Surg 64:147\u2013150","journal-title":"Am Surg"},{"key":"1906_CR63","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/bjs.1800820509","volume":"82","author":"F Makowiec","year":"1995","unstructured":"Makowiec F, Jehle EC, Becker HD, Starlinger M (1995) Clinical course after transanal advancement flap repair of perianal fistula in patients with Crohn\u2019s disease. Br J Surg 82:603\u2013606","journal-title":"Br J Surg"},{"key":"1906_CR64","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/BF02554276","volume":"30","author":"IT Jones","year":"1987","unstructured":"Jones IT, Fazio VW, Jagelman DG (1987) The use of transanal rectal advancement flaps in the management of fistulas involving the anorectum. Dis Colon Rectum 30:919\u2013923","journal-title":"Dis Colon Rectum"},{"key":"1906_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/DCR.0b013e31823c0f74","volume":"55","author":"RS Onkelen van","year":"2012","unstructured":"van Onkelen RS, Gosselink MP, Schouten WR (2012) Is it possible to improve the outcome of transanal advancement flap repair for high transsphincteric fistulas by additional ligation of the intersphincteric fistula tract? Dis Colon Rectum 55:163\u2013166","journal-title":"Dis Colon Rectum"},{"key":"1906_CR66","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/SLA.0000000000001461","volume":"262","author":"H Corte","year":"2015","unstructured":"Corte H, Maggiori L, Treton X, Lefevre JH, Ferron M, Panis Y (2015) Rectovaginal fistula. Ann Surg 262:855\u2013861","journal-title":"Ann Surg"},{"key":"1906_CR67","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/DCR.0b013e31821df266","volume":"54","author":"U Gajsek","year":"2011","unstructured":"Gajsek U, CDArthur DR, Sagar PM (2011) Long-term efficacy of the button fistula plug in the treatment of Ileal pouch-vaginal and Crohn\u2019s-related rectovaginal fistulas. Dis Colon Rectum 54:999\u20131002","journal-title":"Dis Colon Rectum"},{"key":"1906_CR68","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/j.1463-1318.2009.02029.x","volume":"12","author":"C Ruffolo","year":"2010","unstructured":"Ruffolo C, Scarpa M, Bassi N, Angriman I (2010) A systematic review on advancement flaps for rectovaginal fistula in Crohn\u2019s disease: transrectal vs transvaginal approach. Colorectal Dis 12:1183\u20131191","journal-title":"Colorectal Dis"},{"key":"1906_CR69","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/DCR.0b013e3181e536cb","volume":"53","author":"RA Pinto","year":"2010","unstructured":"Pinto RA, Peterson TV, Shawki S, Davila GW, Wexner SD (2010) Are there predictors of outcome following rectovaginal fistula repair? Dis Colon Rectum 53:1240\u20131247","journal-title":"Dis Colon Rectum"},{"key":"1906_CR70","doi-asserted-by":"publisher","first-page":"O61","DOI":"10.1111\/codi.13242","volume":"18","author":"D Mege","year":"2016","unstructured":"Mege D, Frasson M, Maggiori L, Panis Y (2016) Is biological mesh interposition a valid option for complex or recurrent rectovaginal fistula? Colorectal Dis 18:O61\u2013O65","journal-title":"Colorectal Dis"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10151-018-1906-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-018-1906-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-018-1906-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:40:30Z","timestamp":1577925630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10151-018-1906-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1906"],"URL":"https:\/\/doi.org\/10.1007\/s10151-018-1906-y","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"value":"1123-6337","type":"print"},{"value":"1128-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"10 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dominique Bouchard is the recipient of fees for education and consulting from Abbvie, Fran\u00e7ois Pigot is the recipient of fees for lectures from Abbvie, Laurent Siproudhis is the recipient of fees for consulting, teaching and research from Abbvie, Ferring, MSD and Takeda, Laurent Abramowitz is the recipient of fees for research from Abbvie and Takeda, Jean-Luc Faucheron is the recipient of fees for consulting and research from AMI and Medtronic, David Laharie is the recipient of fees for consulting and research from Abbvie, Janssen, MSD and Takeda, Ghislain Staumont, Paul Benfredj, Charl\u00e8ne Brochard, Nadia Fathallah, Thierry Higuero, Yves Panis, Vincent de Parades, and B\u00e9atrice Vinson-Bonnet have no conflict of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}